Warwick Evidence, part of Warwick Medical School, has received an award of over £4 million to continue their work providing essential information to inform decisions on whether to recommend technologies (drugs, other treatments, devices and diagnostics) for use within the NHS.
The team undertake reviews and evidence synthesis on the clinical and cost effectiveness of health care interventions for the NIHR Health Technology Assessment Programme on behalf of a range of policy makers, including the National Institute for Health and Clinical Excellence (NICE). They are one of nine Technology Appraisal Review Teams across the country.
Professor Dame Sally C. Davies FRS FMedSci, Chief Medical Officer and Chief Scientific Adviser at the Department of Health said:
These new awards are important because of the role systematic reviews play in the health research landscape. By removing uncertainties in science and research, systematic reviews help to ensure that only the most effective and best-value interventions are adopted by the NHS and social care providers. The centres we are announcing today will provide high quality systematic reviews infrastructure, enabling our health and care services access to the best possible evidence to inform decisions and choices.”
Visit the Warwick Evidence website for more information on their work.